Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/26/2025

Myocardial Perfusion Scanning in Patients with Pericardial Effusion

Introduction to Pericardial Effusions

  • The European Society of Cardiology recommends that small pericardial effusions (<10 mm) are usually asymptomatic and generally have a good prognosis without requiring specific monitoring 3
  • The European Society of Cardiology states that moderate to large effusions (>10 mm) may worsen over time, with severe effusions potentially evolving toward cardiac tamponade in up to one-third of cases 3
  • The clinical significance of pericardial effusion is primarily related to the size of the effusion, according to the European Society of Cardiology 1

Considerations for Myocardial Perfusion Scanning

  • The European Society of Cardiology recommends echocardiographic assessment before performing MPS to confirm the size of the effusion and absence of hemodynamic compromise 1, 2
  • For patients with small pericardial effusions, the European Society of Cardiology suggests that regular monitoring is sufficient without specific interventions 3
  • The European Society of Cardiology states that no contraindication exists for proceeding with MPS in patients with small pericardial effusions 2

Special Considerations

  • The European Society of Cardiology notes that small pericardial effusions are common after myocardial infarction 4
  • Postinfarction pericardial effusions >10 mm warrant careful evaluation as they may be associated with hemopericardium, according to the European Society of Cardiology 4
  • The American Heart Association recommends that in post-MI patients, careful assessment for tamponade signs should precede any stress testing 5
  • The European Society of Cardiology suggests that the cause of pericardial effusion should guide management decisions 1
  • Inflammatory causes (pericarditis) should be treated with anti-inflammatory medications, according to the European Society of Cardiology 1